Archive for August 5, 2008

Cytos Biotechnology Ltd (SWX:CYTN) announced
results from two randomized, double-blind, placebo-controlled,
multicentre phase II studies
with CYT003-QbG10 monotherapy for the treatment of house dust mite and cat
allergy, and with
CYT005-AllQbG10 combination therapy for the treatment of house dust mite
allergy. The studies were
conducted in order to determine whether QbG10 acts through an
allergen-independent or allergendependent
mechanism Read the rest of this entry »

UC Irvine researchers have identified the brain mechanism that switches off traumatic feelings associated with bad memories, a finding that could lead to the development of drugs to treat panic disorders.
Scientists from UCI and the University of Muenster in Germany found that a small brain protein called neuropeptide S is involved in erasing traumatic responses to adverse memories by working on a tiny group of Read the rest of this entry »

A randomized controlled trial performed by researchers of the University of Amsterdam evaluates writing therapy in posttraumatic stress disorder in the March issue of Psychotherapy and Psychosomatics.
Writing assignments have shown promising results in treating traumatic symptomatology. Yet no studies have compared their efficacy to the Read the rest of this entry »